### 45555 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

EIS No. 20110235, Draft EIS, DOE, WA,

Klickitat Hatchery Complex Program, Proposed Changes to Production Programs for Four Anadromous Fish Species, Klictitat River Subbasin, Klickitat and Yakima Counties, WA,

Comment Period Ends: 09/12/2011,

Contact: Hannah Dondy-Kaplan 503–

230–4071. EIS No. 20110236, Draft EIS, FTA, GA,

Tier 1—Atlanta Beltline City of Atlanta, Proposed Fixed Guideway Transit and Multi-Use Trails System, Right-of-Way Preservation, Fulton County, GA, Comment Period Ends: 09/12/2011, Contact: Keith Melton

404–865–5600. EIS No. 20110237, Final EIS, BLM, WY,

Buckskin Mine Hay Creek II Project, Coal Lease Application WYW– 172684, Wyoming Powder River Basin, Campbell County, WY, Review
Period Ends: 08/29/2011, Contact: Teresa Johnson 307–261–7510. EIS No. 20110238, Draft EIS, NPS, DC,

Anacostia Park Wetland and Resident Goose Management Plan, To Guide

and Direct the Actions of National Park Service (NPS) in the Management of Wetlands and Resident (non-migratory) Canada Geese at Anacostia Park, Implementation, Washington, DC,

Comment Period Ends: 09/26/2011,

Contact: Alex Romero 202–690–5197. EIS No. 20110239, Draft EIS, BLM, 00,

Gateway West Transmission Line Project, Proposed To Analyze the Effects of Authorizing the Proponents (Rocky Mountain Power and Idaho Power) to Construct and Operate the Gateway West Transmission Line Project, Application for Right-of-Way (ROW) Grants to Utilize Portions of National System of Public Lands and Special Use Permits to Utilize Portions of National Forest System Lands in Southern Wyoming, Southern Idaho and Possibly Northern Nevada, Comment Period Ends: 10/ 26/2011, Contact: Walter E. George

307–775–6116. EIS No. 20110240, Draft EIS, NPS, AK,

Denali Park Road and Preserve, Draft Vehicle Management Plan, Implementation, AK, Comment Period

Ends: 09/30/2011, Contact: Miriam

Valentine 907–733–9102. EIS No. 20110241, Draft EIS, NNSA,

NV, Site-Wide EIS—Continued Operation of the Department of Energy/National Nuclear Security Administration, Nevada National Security Site and Off-Site Location in Nevada, Comment Period Ends: 10/ 27/2011, Contact: Linda M. Cohn

702–295–0077. EIS No. 20110242, Final EIS, BLM, CO,

Over The River (OTR) Project, Propose to Install a Temporary Work of Art, Require the Use of Federal, Private and State Lands Adjacent to the River, Western Fremont County

and Southeast Portion of Chaffee County, CO, Review Period Ends: 08/ 29/2011, Contact: Vincent Hopper

719–269–8555. EIS No. 20110243, Draft EIS, FHWA, 00,

Tier 1—National Highway System (NHS) Corridor, Propose to Develop an Improved Transportation Connecting (US–220) between I–68 and Corridor H, Grant, Hardy, Hampshire, Mineral Counties, WV and Allegany County, MD, Comment

Period Ends: 10/14/2011, Contact: Greg Bailey 304–558–9722. EIS No. 20110244, Draft EIS, FHWA,

OR, US–97 Bend North Corridor Project, Propose to Improve a Segment of US–97 in Deschutes County, Oregon between the Deschutes Market Road/Tumalo Junction Interchange and the Empire Avenue Interchange, Deschutes County, OR, Comment

Period Ends: 09/12/2011, Contact:

Chris Bucher 503–399–5749.

Amended Notices

EIS No. 20110225, Final EIS, FHWA,

TN, Interstate 55 Interchange at E.H. Crump Boulevard and South Boulevard Project, To Provide a Balanced Solution for Safety and Capacity Issues at the I55 Interchange, City of Memphis, Shelby County, TN,

Review Period Ends: 08/22/2011,

Contact: Charles J. O’Neill 615–781–

5772. Review to FR Notice 07/22/2011:

Correction to Review Period End from

08/15/2011 to 08/22/2011. EIS No. 20110228, Final EIS, FHWA, IN,

I–69 Evansville to Indianapolis Tier 2 Section 4 Project, From U.S. 231 (Crane NSWC) to IN–37 South of Bloomington in Section 4, Greene and
Monroe Counties, IN, Review Period

Ends: 08/22/2011, Contact: Michelle

Allen 317–226–7344.
Review to FR Notice 07/22/2011:

Correction to Review Period End from

08/15/2011 to 08/22/2011. EIS No. 20110231, Final EIS, BLM, NV,

Salt Wells Energy Projects, Proposal for Three Separate Geothermal Energy and Transmission Projects, Implementation, Churchill County,
NV, Review Period Ends: 08/22/2011,

Contact: Colleen Sievers 775–885–

6168. Review to FR Notice 07/22/2011:

Correction to Review Period End from

08/15/2011 to 08/22/2011. EIS No. 20110234, Final EIS, FHWA, WI,

US 41 Improvement Project, Extend from Depere—Suamico (Memorial Drive to County M), Brown County, WI, Review Period Ends: 08/22/2011,

Contact: George Poirier 608–829–

7500. Review to FR Notice 07/22/2011:

Correction to Review Period End from

08/15/2011 to 08/22/2011.

Dated: July 26, 2011.

Cliff Rader,
Acting Director, NEPA Compliance Division, Office of Federal Activities.

[FR Doc. 2011–19234 Filed 7–28–11; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION**

**AGENCY**

**[EPA–HQ–OPP–2011–0550; FRL–8882–2]**

**Nominations to the FIFRA Scientific Advisory Panel; Request for** 

**Comments**

**AGENCY :**  Environmental Protection Agency (EPA).

**ACTION :**  Notice.

**SUMMARY :**  This notice provides the names, addresses, professional affiliations, and selected biographical data of persons nominated to serve on the Scientific Advisory Panel (SAP) established under section 25(d) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The Panel was created on November 28, 1975, and made a statutory Panel by amendment to FIFRA, dated October 25, 1988. The Agency, at this time, anticipates selecting two new members to serve on the panel as a result of membership terms that will expire next year. Public

comments on the nominations are invited, as these comments will be used to assist the Agency in selecting the new

chartered Panel members.

**DATES :**  Comments, identified by docket ID number EPA–HQ–OPP–2011–0550, must be received on or before August

29, 2011.

**ADDRESSES :**  Submit your comments, identified by docket identification (ID) number EPA–HQ–OPP–2011–0550, by one of the following methods:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the on-line instructions for submitting comments.

• Mail: Office of Pesticide Programs (OPP) Regulatory Public Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington,

DC 20460–0001.

• Delivery: OPP Regulatory Public Docket (7502P), Environmental Protection Agency, Rm. S–4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only accepted during the Docket Facility’s normal hours of operation


### 45556 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

(8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays). Special arrangements should be made

for deliveries of boxed information. The Docket Facility telephone number is (703) 305–5805.

Instructions. Direct your comments to docket ID number EPA–HQ–OPP–2011– 0550. If your comments contain any information that you consider to be CBI or otherwise protected, please contact the Designated Federal Official (DFO)

listed under **FOR FURTHER INFORMATION**

**CONTACT** to obtain special instructions before submitting your comments. EPA’s policy is that all comments

received will be included in the docket without change and may be made

available on-line at http:// www.regulations.gov, including any personal information provided, unless

the comment includes information

claimed to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Do not submit information that you

consider to be CBI or otherwiseprotected through regulations.gov or email. The regulations.gov Web site is an ‘‘anonymous access’’ system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through regulations.gov, your e-mail address will be automatically captured and included as part of the comment that is placed in the docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD–ROM you submit. If EPA cannot read your

comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your

comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects

or viruses.

Docket: All documents in the docket

are listed in the docket index available

at http://www.regulations.gov. Although listed in the index, some information is not publicly available, e.g., CBI or other

information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket

materials are available either in the

electronic docket at http:// www.regulations.gov, or, if only available in hard copy, at the OPP Regulatory Public Docket in Rm. S– 4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket Facility telephone number is (703) 305–5805.

**FOR FURTHER INFORMATION CONTACT :**  Joseph E. Bailey, DFO, Office of Science Coordination and Policy (7201M), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number: (202) 564–2045; fax number: (202) 564–

8382; e-mail address: bailey.joseph@epa.gov.

**SUPPLEMENTARY INFORMATION :** 

I. General Information

A. Does this action apply to me?

This action is directed to the public in general. This action may, however, be of interest to persons who are or may be required to conduct testing of chemical substances under the Federal Food, Drug, and Cosmetic Act (FFDCA), FIFRA, and the Food Quality Protection Act of 1996 (FQPA). Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the DFO

listed under **FOR FURTHER INFORMATION**

**CONTACT**

. B. What should I consider as I prepare my comments for EPA?

When submitting comments,

remember to:

1. Identify the document by docket ID number and other identifying information (subject heading, Federal Register date and page number).

2. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations (CFR) part

or section number.

3. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes.

4. Describe any assumptions and provide any technical information and/ or data that you used.

5. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced.

6. Provide specific examples to illustrate your concerns and suggest

alternatives.

7. Explain your views as clearly as possible, avoiding the use of profanity or personal threats.

8. Make sure to submit your comments by the comment period

deadline identified. II. Background

The FIFRA SAP serves as the primary scientific peer review mechanism of EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and is structured to provide scientific advice,

information and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health

and the environment. The FIFRA SAP is a Federal advisory committee,
established in 1975 under FIFRA, that operates in accordance with requirements of the Federal Advisory Committee Act (FACA). The FIFRA SAP is composed of a permanent panel consisting of seven members who are appointed by the EPA Administrator from nominees provided by the National Institutes of Health (NIH) and the National Science Foundation (NSF). FIFRA, as amended by FQPA,

established a Science Review Board consisting of at least 60 scientists who

are available to the SAP on an ad hoc basis to assist in reviews conducted by the FIFRA SAP. As a peer review mechanism, the FIFRA SAP provides
comments, evaluations and recommendations to improve the effectiveness and quality of analyses made by Agency scientists. Members of

the FIFRA SAP are scientists who have sufficient professional qualifications, including training and experience, to provide expert advice and recommendation to the Agency.

In accordance with the statute, the SAP is composed of a permanent panel of seven members, selected and appointed by the Administrator of EPA from nominees submitted by both the NSF and the NIH. The Agency, at this time, anticipates selecting two new members to serve on the panel as a result of membership terms that will expire next year. The Agency requested nominations of experts to be selected from the fields of pharmacology, immunotoxicology, toxicology risk assessment, environmental toxicology

and/or biostatistics with demonstrated experience and expertise in all phases of the risk assessment process including: Planning, scoping, and problem formulation; analysis; and interpretation and risk characterization (including the interpretation and communication of uncertainty). Nominees should be well published and current in their field of expertise. The statute further stipulates that we publish the name, address and professional affiliation in the Federal Register

.


### 45557 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

III. Charter

A Charter for the FIFRA SAP dated October 22, 2010, was issued in accordance with the requirements of the Federal Advisory Committee Act, Public Law 92–463, 86 Stat. 770 (5 U.S.C. App. I).

A. Qualifications of Members

Members are scientists who have sufficient professional qualifications, including training and experience, to be capable of providing expert comments as to the impact of pesticides on health and the environment. No persons shall be ineligible to serve on the Panel by reason of their membership on any other advisory committee to a Federal department or agency or their employment by a Federal department or agency (except the EPA). The Deputy Administrator appoints individuals to serve on the Panel for staggered terms of 4 years. Panel members are subject to the provisions of 40 CFR part 3, subpart F, Standards of Conduct for Special Government Employees, which include rules regarding conflicts of interest. Each nominee selected by the Deputy Administrator, before being formally appointed, is required to submit a confidential statement of employment and financial interests, which shall fully disclose, among other financial interests, the nominee’s sources of research support, if any.

In accordance with section 25(d)(1) of FIFRA, the Deputy Administrator shall require all nominees to the Panel to furnish information concerning their professional qualifications, educational background, employment history, and scientific publications.

B. Applicability of Existing Regulations

With respect to the requirements of section 25(d) of FIFRA that the Administrator promulgate regulations regarding conflicts of interest, the Charter provides that EPA’s existing regulations applicable to Special Government Employees, which include advisory committee members, will apply to the members of the SAP. These regulations appear in 40 CFR part 3, subpart F. In addition, the Charter provides for open meetings with opportunities for public participation.

C. Process of Obtaining Nominees

In accordance with the provisions of section 25(d) of FIFRA, EPA, on February 24, 2011, requested that the

NIH and the NSF nominate scientists to fill vacancies occurring on the Panel. The Agency requested nominations of experts in the fields of pharmacology, immunotoxicology, toxicology risk assessment, environmental toxicology and/or biostatistics with demonstrated experience and expertise in all phases of the risk assessment process including: Planning, scoping, and problem formulation; analysis; and interpretation and risk characterization (including the interpretation and communication of uncertainty). NIH and NSF responded by letter, providing the Agency with a total of 38 nominees. Copies of these letters, with the listed nominees, are available in the public docket referenced in Unit I.B.1., of this notice. Of the 38 nominees, 20 are interested and available to actively participate in SAP meetings (see Unit IV. Nominees). The following 18 nominees are not

available:

1. Kim Boekelheide, PhD, Brown University, Providence, RI.

2. Paul W. Brandt-Rauf, DrPH, MD, ScD, University of Illinois, Chicago, IL.

3. Patricia A. Buffler, PhD, MPH, University of California, Berkeley, CA.

4. John Cashman, PhD, Human Biomolecular Research Institute, San Diego, CA.

5. Deborah A. Cory-Slechta, PhD, University of Rochester School of Medicine & Dentistry, Rochester, NY.

6. Carlos Davidson, PhD, San Francisco State University, San
Francisco, CA.

7. Elaine Faustman, PhD, University of Washington, Seattle, WA.

8. Clement Furlong, PhD, University of Washington, Seattle, WA.

9. John P. Giesy, PhD, University of Sasketchewan, Saskatoon, Saskatchewan, Canada.

10. Anumantha Kanthasamy, PhD, Iowa State University, Ames, IA.

11. Stephen A. McCurdy, M.D., M.P.H., University of California-Davis,
Davis, CA.

12. Marie Lynn Miranda, PhD, Duke University, Durham, NC.

13. James J. Pestka, PhD, Michigan State University, East Lansing, MI.

14. Walter J. Rogan, M.D., National

Institute of Environmental Health Sciences, Research Triangle Park, NC .

15. Jason Rohr, PhD, University of South Florida, Tampa, FL.

16. Anthony Scialli, M.D., Tetra Tech Services, Arlington, VA.

17. Lester G. Sultatos, PhD, University of Medicine & Dentistry of New Jersey, Newark, NJ.

18. Stephen C. Waring, DVM, PhD, Marshfield Clinic Research Foundation, Marshfield, WI.

IV. Nominees

The following are the names, addresses, professional affiliations, and selected biographical data of nominees being considered for membership on the FIFRA SAP. The Agency anticipates selecting two of the nominees to fill vacancies occurring next year.

1. Daniel W. Anderson, PhD, University of California Davis, Davis,

CA.

i. Expertise: Ecotoxicology. ii. Education: B.S., in Zoology from North Dakota State University; M.S., in Wildlife Ecology and PhD, in Wildlife Ecology and Zoology from University of

Wisconsin.

iii. Professional Experience: Dr.

Daniel Anderson is Professor Emeritus at the University of California Davis,

where he was Director and co-founder of the Marine Bird Ecology and Ecotoxicology Project, and former Chair of the UC Davis Department of Wildlife, Fish, and Conservation Biology. He joined the faculty of UC Davis in 1976, and is continuing his research efforts on

environmental contaminants and their effects on seabird populations, ecology, habitat, migration and related areas. While at UC Davis, he taught undergraduate courses in Wildlife Ecotoxicology, Avian Biology, and Field Biology Techniques; as well as graduate seminars in Ecotoxicology and Avian Ecology, and also served as founder and Chairperson of the Ecotoxicology ‘‘area of emphasis’’ in the Ecology Graduate Group at UC Davis. Prior to that, while at University of Wisconsin, he was instrumental in hypothesizing and documenting a specific link between the DDT-metabolite, DDE, and widespread eggshell thinning in susceptible species of birds. In late 1970, Dr. Anderson served as a Research Biologist for the U.S. Fish and Wildlife Service, working on pesticide contaminants in wildlife of California and Mexico, primarily to study and document contaminant changes in seabirds and raptors, in particular, the decline of DDE and associated beginnings of the recovery of

the Brown Pelican. Dr. Anderson and his co-workers also published papers on the dynamics and effects of agricultural contaminants in migratory waterbirds. Dr. Anderson retired from teaching and administration in 2009, but continues his life-long commitment to ecotoxicology, seabird biology, and

conservation. Dr. Anderson’s current

research involves studies of contamination effects, distribution, and dynamics of organic and inorganic

materials in birds from California and Baja California coastal and wetland

environments. Dr. Anderson is also actively involved in the conservation and management of avian populations

and their habitats.

2. John C. Bailar, III, M.D., PhD, The University of Chicago, Chicago, IL.

i. Expertise: Statistics, epidemiology &

risk assessment.


### 45558 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

ii. Education: B.A. in Chemistry from the University of Colorado; M.D. in Medicine from Yale University; PhD in Statistics from the American University.

iii. Professional Experience: Dr. John

Bailar is Professor Emeritus at the University of Chicago and founding Chair of the University’s Department of Health Studies. His professional interests have centered for years on the causes and prevention of disease. More recently he has focused on improving quality and performance in science generally. He was at the U.S. National Cancer Institute 1956–1980, Harvard University 1980–1988, and McGill University 1988–1995, before he went to Chicago. At present he is Scholar in

Residence at the National Academies.

He was a MacArthur Fellow 1990–1995. He has published widely in the statistics and epidemiology literature, including, recently, the health effects of air pollution. His areas of expertise include statistics, epidemiology and risk

assessment. He has chaired over 20 National Academy committees and

served on numerous others and has also

served as monitor of more than 20 Academy reports.

3. Kenneth Barry Delclos, PhD, U.S. Food and Drug Administration (FDA), Jefferson, AR.

i. Expertise: Toxicology, pharmacology, endocrine disruption.

ii. Education: A.B. in Biochemistry from Cornell University; PhD in Pharmacology from Harvard University;

Postdoctoral work at McArdle Laboratory for Cancer Research, University of Wisconsin.

iii. Professional Experience: Dr. K. Barry Delclos is a Research Pharmacologist in the Division of Biochemical Toxicology at the FDA’s National Center for Toxicological Research since 1985, where he has

conducted research in diverse areas. Earlier efforts focused largely on chemical carcinogenesis, but more recently his focus has been on toxicities associated with endocrine active agents. He continues to serve as Principal Investigator on a series of studies conducted under an Interagency Agreement between the FDA and the National Toxicology Program to evaluate aspects of the hypothesis that exposure to low levels of hormonally active agents, particularly during development, adversely affects human health, including reproductive function and carcinogenesis. He has served on interagency committees evaluating carcinogens and endocrine active agents, including several EPA advisory panels relating to endocrine active

chemicals. 4. Russell L. Carr, PhD, Mississippi State University, Mississippi State, MS.

i. Expertise: Developmental neurotoxicology.

ii. Education: B.S. in Biology and Chemistry from Delta State University; M.S. in Zoology and PhD in Animal Physiology from Mississippi State University; Postdoctoral work at Mississippi State University.

iii. Professional Experience: Dr.

Russell Carr is an Associate Professor in

the Center for Environmental Health Sciences, in the College of Veterinary Medicine at Mississippi State University. Prior to serving in his current faculty position, Dr. Carr completed postdoctoral training (1995) and served as a Research Toxicologist (1995–1999) at Mississippi State. Dr. Carr’s primary research interests are in the area of developmental neurotoxicology with emphasis on

environmental chemicals. One focus is investigating the mechanisms by which developmental organophosphorus insecticide exposure alters the neurochemistry of the brain and induces long-term changes in behavior. Another focus is the development of a short lived aquatic vertebrate model to study the lifetime effects of developmental exposure. Dr. Carr is currently the

Research Coordinator/Evaluator for the Indianola Promise Community of the

Delta Health Alliance. He is active in both the national and local chapters, the Society of Toxicology (SOT). Dr. Carr

has served as an ad hoc panel member

on several U.S. EPA FIFRA SAP’s.

5. Marion Ehrich, PhD, VirginiaMaryland Regional College of Veterinary Medicine, Blacksburg, VA.

i. Expertise: Pharmacology and toxicology.

ii. Education: B.S. in Pharmacy from South Dakota State University; M.S. in Pharmacology/Toxicology from the University of Chicago; and PhD in Pharmacology/Toxicology from the University of Connecticut at Storrs.

iii. Professional Experience: Dr.

Marion Ehrich is a Professor at the Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) in Blacksburg, VA, and VT Carilion School of Medicine in Roanoke, VA. In addition to teaching pharmacology and toxicology to medical, veterinary and graduate students, her professional responsibilities include service in the Veterinary Medical Teaching Hospital Pharmacy and in the Toxicology Diagnostic Laboratory. She has been teaching at VMRCVM since 1980, when

she also became a member of the Society of Toxicology (SOT) and a Diplomate of the American Board of Toxicology. She was elected a fellow of the Academy of Toxicological Sciences in 1999. Dr. Ehrich’s primary research

activities are associated with the comparative neurotoxicities of antiesterase pesticides, with both in vivo
and in vitro models used for study. Dr. Ehrich was the 2003–2004, President of

the SOT and their 2010 Merit Awardee.

She served as Treasurer for the Board of

Directors of the American Board of Toxicology (1985–89), Secretary for the SOT (1992–94), and Treasurer for the Academy of Toxicological Sciences (2006–09). She has also chaired SOT’s Education Committee (1990–92), SOT’s Regulatory Affairs and Legislative Action Committee (1997–98), SOT’s Neurotoxicology Specialty Section (2008–2009), and the Toxicology Education Foundation (2000–2001). In addition, she served on the Executive

Board of the Council for Scientific Society Presidents. She currently serves

on the National Research Council’s Committee on Toxicology and editorial boards for the International Journal of Toxicology, the Journal of Applied Toxicology, and NeuroToxicology.

6. Jay Gan, PhD, University of California, Riverside, CA.

i. Expertise: Environmental chemistry.

ii. Education: PhD in Pesticide Chemistry from Zhejiang University (Hangzhou, China); Postdoctoral fellow with IAEA’s Laboratories in Seibersdorf, Austria (1990–1991) and University of Minnesota in St. Paul, MN (1991–1993).

iii. Professional Experience: Dr. Jianying (Jay) Gan is currently a Professor of Environmental Chemistry, in the Department of Environmental Sciences at the University of California (UC) Riverside, where he served as the Department Chair from 2007 to 2010. He joined the UC Riverside faculty in 2001, following 8 years service as a Research Scientist with the (USDA) Agricultural Research Service Laboratory in Riverside, CA. His research is related to environmental fate, transport, and risk assessment of pesticides, wastewater trace pollutants, and persistent organic pollutants, with an emphasis on water quality and risk mitigation. To date he has authored over 175 technical journal articles, and edited four pesticide books through American Chemical Society. Dr. Gan, currently supervises five PhD students majoring in Environmental Sciences or Environmental Toxicology. He teaches ‘‘Fate and Transport of Contaminants in Soil’’ to undergraduate students and ‘‘Environmental Organic Chemistry’’ to graduate students. Dr. Gan, was elected a Fellow of American

Association for the Advancement of Science (AAAS) in 2008, a Fellow of American Society of Agronomy (ASA)


### 45559 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

in 2006, and a Fellow of Soil Science Society of America (SSSA) in 2010.

7. Ellen Gold, PhD, University of California Davis School of Medicine,
Davis, CA.

i. Expertise: Epidemiology, effects of environmental exposures on women’s health, endocrine function and reproductive health.

ii. Education: B.A. in Bacteriology and M.A. in Zoology from the University of California—Los Angeles; PhD in Epidemiology from The Johns Hopkins University School of Hygiene and

Public Health.

iii. Professional Experience: Dr. Ellen

Gold is the current Chair of the Department of Public Health Sciences

and Chief of the Division of Epidemiology, in that Department in the University of California Davis School of

Medicine and former Chair of the Graduate Group in Epidemiology. After receiving her PhD she became a faculty member at The Johns Hopkins University until she moved to the UC Davis faculty in 1988. She has been principal investigator on a number of NIH-funded, peer-reviewed grants and has had continuous NIH research grant funding for over 20 years. These research grants have largely focused over the past 30 years on lifestyle and

environmental factors that affect women’s reproductive health and

cancer risk and include her work for the past 15 years studying the natural history of the menopausal transition, including hormonal and symptomatic changes, in a longitudinal study of a large, multi-racial/ethnic national

cohort. She has also authored or coauthored over 150 peer-reviewed publications. She has mentored numerous graduate students and junior faculty and has received a number of outstanding faculty and mentoring awards, as co-director of the UC Davis Building Interdisciplinary Research Careers in Women’s Health program and

is a Fellow in the American Association

for the Advancement of Science.

8. Pertti (Bert) J. Hakkinen, PhD, National Institutes of Health, Bethesda,

MD.

i. Expertise: Toxicology. ii. Education: B.A. in Biochemistry and Molecular Biology from the University of California—Santa Barbara; PhD in Comparative Pharmacology and Toxicology from the University of California, San Francisco, CA.

iii. Professional Experience: Dr. Pertti (Bert) Hakkinen is the Senior Toxicologist and Toxicology and

Environmental Health Science Advisor in the Division of Specialized

Information Services at the National Library of Medicine (NLM), National Institutes of Health (NIH). He provides leadership on the development of new resources in toxicology, exposure science, and risk assessment, and enhancements to existing NLM

resources in these fields. Dr. Hakkinen is the project leader for the Wireless Information System for Emergency Responders (WISER) and Chemical Hazards Emergency Medical Management (CHEMM) tools, represents NLM on various committees, and provides leadership for NLM’s participation in national and international efforts in toxicology-, exposure-, and risk assessment-related

information. He also is the co-director of

a Public Health Informatics course offered since 2009, at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland, and is the vice-chair of the SAP for the Mickey Leland National

Urban Air Toxics Research Center (NUATRC) in Houston, Texas. During his career, Dr. Hakkinen has held numerous leadership positions in the field of toxicology and risk assessment. Before joining the NIH in 2008, Dr. Hakkinen served for several years on the auxiliary staff of the European Commission (EC) at the EC’s Institute for Health and Consumer Protection, Joint Research Centre, in Italy. He has also held positions with Toxicology Excellence for Risk Assessment (TERA) and Gradient Corporation in the United

States and at the Procter and Gamble Company in the United States and Japan. Dr. Hakkinen is a member of the Society of Toxicology (SOT) and a charter member of the Society for Risk Analysis (SRA) and the International Society of Exposure Science (ISES). He

is a co-editor and co-author of the latest

edition of the Encyclopedia of Toxicology, and of the last two editions

of the Information Resources in Toxicology book. Dr. Hakkinen has

authored and co-authored numerous other publications.

9. Dale Hattis, PhD, Clark University,
Worcester, MA.

i. Expertise: Risk assessment methodology.

ii. Education: B.A. in Biochemistry from the University of California, Berkeley, CA. PhD in Genetics from Stanford University.

iii. Professional Experience: Dr. Dale

Hattis is Research Professor with the George Perkins Marsh Institute at Clark University. For the past 35 years he has been engaged in the development and application of methodology to assess the health, ecological, and economic impacts of regulatory actions. His work has focused on approaches to incorporate inter-individual variability data and quantitative mechanistic

information into risk assessments for both cancer and non-cancer endpoints.Recent research has explored PBPKbased dosimetry for chlorpyrifos based

on observations of blood levels in pregnant women and their newborn infants, quantitative analysis of

uncertainties for cancer and non-cancer health risks of dioxin, age-related differences in sensitivity to carcinogenesis and other effects, a taxonomy of different non-mutagenic modes of action for carcinogenesis withlikely differential implications for agerelated sensitivity, PBPK modeling of acrylamide dose in rats and humans, and mechanism-based dose response modeling of carcinogenic effects from ionizing radiation. He is a leader in efforts to replace the current system of uncertainty factors with distributions based on empirical observations. He has

been a member of the Environmental

Health Committee of the EPA Science Advisory Board, and for several years he has served as a member of the FQPA

Science Review Board. He has also

served as a member of the National

Research Council Committee on Estimating the Health-Risk-Reduction Benefits of Proposed Air Pollution Regulations. He has been a Councilor and is a Fellow of the Society for Risk Analysis.

10. David Hawthorne, PhD, University of Maryland, College Park, MD.

i. Expertise: Entomology. ii. Education: B.S. in Biology and Economics from Kent State University; M.S. in Entomology from North Carolina State University; PhD in Entomology from Cornell University; Postdoctoral training at the University of Oregon and Cornell University.

iii. Professional Experience: Dr. David J. Hawthorne is an Associate Professor at the University of Maryland, College Park, in the Department of Entomology, College of Computational, Mathematical and Natural Sciences, where he has served on the faculty since 1997. At Cornell University, Dr. Hawthorne did his thesis work on insect adaptation to resistant crop cultivars, focusing on quantitative genetics approaches tounderstanding that process. His postdoctoral training was done at the University of Oregon and at Cornell University. At the University of Oregon, he worked on molecular genetics of variation in anthocyanin expression in maize. At Cornell he developed markers and populations that would result in the first genetic linkage map of Colorado potato beetle and the mapping of

resistance in that insect to the

insecticide esfenvalerate. The Hawthorne lab investigates the genetic


### 45560 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

and ecological factors underlying responses of insects to novel host plants and agricultural pesticides. This work has been applied to increase understanding of the processes of speciation and the risk assessment and management of pesticide responses by both pest and beneficial insects. Dr.

Hawthorne has an active collaboration at the United States Department of Agriculture/Agricultural Research Service (USDA/ARS) at Beltsville, MD, on the effects of chronic exposure of pesticides to honey bees and on the effects of pesticide combinations on honey bee health. He has authored 21 articles on insect molecular ecology and genetics, has served on several grant

review committees for the USDA and the NIH, and on review panels for development of resistance-preventing strategies and re-registration of Bt corn

for the EPA. Research in Dr. Hawthorne’s laboratory is currently funded by grants from the USDA.

11. Lawrence Kapustka, PhD, SLR Consulting, Calgary, Alberta, Canada.

i. Expertise: Environmental & ecological risk assessment.

ii. Education: B.S.Ed in Biology and M.S. in Botany from the University of Nebraska; PhD Plant Physiological Ecology from the University of

Oklahoma.

iii. Professional Experience: Dr. Lawrence Kapustka has over 35 years of experience in environmental and ecological risk assessment. He began his professional career in academia with 3years at the University of WisconsinSuperior and 10 years at Miami University teaching courses, conducting research programs, and advising graduate students in a range of basic and applied subjects including ecology, forestry, plant physiology, microbial ecology, and environmental sciences.

He followed that academic start to his career with 3 years at the EPA research laboratory in Corvallis, Oregon where he led the Plant Toxicology and Hazardous Waste research programs. Since 1990, Dr. Kapustka has worked in consulting firms including his own private practice for over 15 years. Dr. Kapustka has gained international recognition for his leadership role in advancing the practice of environmental risk

assessment. His contributions have included the development of test methods used to evaluate toxicity of chemicals to ecological receptors and continual refinement of approaches to

assess environmental risks. He has

collaborated with clients to advance the state-of-the-science employed in risk assessments, including the use of the basics of systems ecology and landscape ecology. Most recently, Dr. Kapustka has been working with colleagues and clients to incorporate spatially-explicit landscape perspectives to achieve integrated holistic risk assessments to inform environmental management decisions. He has helped clients with strategic planning to address environmental challenges, the design of sampling plans to characterize baseline conditions, and design of monitoring plans to track environmental compliance. Dr. Kapustka has worked with industries, public interest groups, and regulators from several jurisdictions (Federal, state/provincial, and international) to develop policies and approaches to meet emerging concerns, including those in the growing field of nanotechnology and radiation ecology. He has provided litigation support pertaining to natural resource damage claims, permitting, and site contamination cases. Dr. Kapustka has been responsible for business development, marketing, project management, and general business operations. He volunteers as a member

of the executive committee of the Calgary Chapter of Ducks Unlimited

Canada.

12. David J. Kent, PhD, Keller & Heckman LLP, Washington, DC.

i. Expertise: Environmental risk

assessment.

ii. Education: B.S. in Biology from University of Bridgeport; M.S. in Environmental Science from Rutgers University; PhD, in Environmental Science and Policy from George Mason University.

iii. Professional Experience: Dr. David Kent has 28 years of consulting experience, primarily in the area of chemical and pesticide regulation for

both domestic and international companies. He assists clients in assessing available data, manages consortia, conducts environmental fate and transport modeling, and performs

environmental risk assessments. Dr.

Kent is a leader in the assessment and management of High Production Volume (HPV), Medium Production Volume (MPV), and Persistent Bioaccumulative and Toxic (PBT)

chemicals in both the United States and Europe. He assesses potential risks of chemical and pesticide use and has helped companies in a wide variety of specialty areas, including chemicals, pesticides, and consumer products. Dr. Kent is very active in advising companies in how best to meet their obligations under the European REACH chemical control program, the European Union (EU) classification and labeling regulation, and the EU Biocides Directives and Regulation. He has also prepared numerous data dossiers for client submission to regulatory agencies, including proprietary reports for submission under REACH, FIFRA, BPD, TSCA, HPV, FDA, and other regulatory and voluntary programs. Dr. Kent is actively involved in and commonly speaks at regional, national, and international scientific organizations. He has served as president of regional chapters of both the Society of Environmental Toxicology and Chemistry (SETAC) and the Society for Risk Analysis (SRA). He chaired the Program Committee for the 26th Annual SETAC meeting and routinelyparticipates at trade associationsponsored conferences, often as the moderator for panels. Dr. Kent has

authored or co-authored more than 100 scientific articles, presentations, and other documents for both peer-reviewed journals and technical newsletters. Topics have included preparations and requirements for REACH, probabilistic ecological risk assessment of pesticides, the proposed Biocide Products Regulation, ecological risk assessment for wetlands, policy implications of emerging chemical regulations, and the

status and trends of the HPV Chemical assessment programs in the United States and Europe.

13. Lynda Lanning, D.V.M., DABT, National Institutes of Health, Bethesda,

MD.

i. Expertise: Toxicology and pathology.

ii. Education: B.S. in Animal Science and Zoology from North Carolina State University; D.V.M from Auburn University.

iii. Professional Experience: Dr. Lynda Lanning is a Health Administrator in the Office of Regulatory Affairs, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health. She completed a pathology residency at Argonne National Laboratory and is a Diplomate of the American Board of Toxicology. Her expertise is in toxicologic pathology, toxicology, safety assessment and drug development. Dr. Lanning’s diverse professional experience as a toxicologic pathologist includes work with the National Toxicology Program, medical device product development, contract research industry nonclinical toxicology, regulatory nonclinical pharmaceutical safety assessment and compound development, and biologic and therapeutic drug development of unique compounds for biodefense, global and orphan diseases. She is responsible for making complex regulatory and drug development

recommendations based on the results of nonclinical studies. Dr. Lanning is


### 45561 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

involved in the technical design and analysis of nonclinical studies for compounds in early and late stages of development, evaluation of the effectiveness and quality of nonclinical studies and safety assessment of compounds in development. She has authored numerous peer-reviewed publications and book chapters and is

an active member of both national and international professional societies related to toxicology and toxicologic pathology.

14. James McManaman, PhD, University of Colorado—Denver,
Aurora, CO.

i. Expertise: Biochemistry, neurobiology and reproductive health.

ii. Education: B.S. in Chemistry from University of Northern Colorado; PhD in Biochemistry from University of Colorado—Boulder; Post Doctoral Fellow at Baylor College of Medicine.

iii. Professional Experience: Dr. James

McManaman is a Professor of Obstetrics and Gynecology, and Chief of the Division of Reproductive Sciences at the University of Colorado, Anschutz Medical Campus. He joined the Neurology Faculty at Baylor College of

Medicine where he worked on

motoneuron survival factors. Dr. McManaman was recruited to Synergen Inc., in 1992, as head of their Neuroscience Group. Following the sale of Synergen to Amgen in 1993, Dr.

McManaman returned to academics at the University of Colorado’s medical campus where he remains. At the University of Colorado, Dr. McManaman developed active interest in mammary gland biology, lipid metabolism, preterm birth and perinatal biology, which are currently his primary

research interests. Dr. McManaman is

the Research Director of the NIH funded Women’s Reproductive Health Research Program at the University of Colorado, and he directs the University’s Frontiers in Pregnancy Research Symposia, a nationally recognized symposia that focuses on biological, psychosocial and clinical research related to pregnancy and perinatal biology. Dr. McManaman is also the co-director of the Adipose Biology Program of the University of Colorado’s Obesity Research Initiative. He has served on a number of advisory panels including being a regular member of the Integrated Clinical Endocrinology and Reproduction (ICER) Study Section at NIH from 2005–2009,

and an ad hoc reviewer for a variety of other NIH Study Sections.

15. Prakash Nagarkatti, PhD, University of South Carolina School of Medicine, Columbia, SC.

i. Expertise: Immunotoxicology. ii. Education: B.Sc. in Botany and Chemistry and M.Sc. in Microbiology from Karnatak University; PhD, in Immunology from Jiwaji University/ Defense R & D Establishment, India; Postdoctoral research in Immunology at McMaster University and University of Kentucky School of Medicine.

iii. Professional Experience: Dr. Prakash Nagarkatti is currently a South Carolina Distinguished Professor and

Associate Dean for Basic Science at the School of Medicine, University of South Carolina (USC), as well as the Director of the NIH-supported Center of Research Excellence in Inflammatory and

Autoimmune Diseases. From 2005 to 2010, he also served as an advisor to the vice president for research at USC. He joined Virginia Tech as an assistant professor in 1986, and rose to become full professor. In 2000, Dr. Nagarkatti joined the Department of Pharmacology and Toxicology at the Medical College of Virginia, Virginia Commonwealth University as Wazeter Distinguished Professor and Director, Immunotoxicology. Dr. Nagarkatti’s research has been continuously supported by numerous grants from NIH, NSF/EPA, and American Cancer Society totaling more than $21 million. Currently, he serves as the Director and Principal Investigator on a $6 million NIH Interdisciplinary Center of Research Excellence in Inflammatory

and Autoimmune Diseases. Dr. Nagarkatti has published over 150 scientific papers in high-impact journals

and has won numerous awards nationally and internationally including those for teaching and scholarly activity.

He has chaired and served as a member on numerous NIH Study Sections and has been invited to give keynote/plenary talks at international meetings. Dr. Nagarkatti has also served on a number of advisory and review panels nationally and internationally, for Federal government and private foundations. Dr. Nagarkatti is one of the pioneers in the area of immunotoxicology, having published papers in this field from early 1980s. Currently, his lab has been investigating the effect of a wide range of environmental contaminants, endocrine disruptors, drugs, and botanicals on the immune response. His laboratory was instrumental in demonstrating for the first time that dioxin (TCDD) triggers apoptosis in immune cells through activation of AhR receptor. His research in immunotoxicology has received recognition and awards from the Society of Toxicology. More recently, Dr. Nagarkatti has been working on the impact of epigenetic regulation on the immune system and testing the ‘‘fetal basis of adult disease’’ hypothesis using endocrine disruptors. His research has provided evidence to support this concept by demonstrating how exposure to endocrine disruptors during pregnancy alters T cell development in the fetus and how this impacts the immune response and susceptibility to immunological disorders, infections and cancer, during adult life.

16. Harry M. Ohlendorf, PhD, CH2M
HILL, Inc., Sacramento, CA.

i. Expertise: Ecological risk

assessment & fisheries/wildlife ecotoxicology.

ii. Education: B.S. in Wildlife Management, M.S. in Wildlife Science and PhD, in Wildlife Science from Texas A&M University.

iii. Professional Experience: Dr. Harry Ohlendorf is Technology Fellow at CH2M Hill, Inc., and has more than 39 years of experience in evaluating the impacts of environmental contaminants on wildlife in aquatic and terrestrial ecosystems, including more than 21 years at CH2M Hill and more than 18 years with U.S. Fish and Wildlife Service (USFWS). He began his career in 1971, as a Wildlife Research Biologist

with the USFWS Patuxent Wildlife Research Center, in Laurel, Maryland,

where he served as Assistant Director for 7 years and remained actively involved in pollution ecology research. In 1980, he became the leader of the

USFWS Pacific Coast Research Station in Davis, California, and studied the occurrence and impacts of contaminants in aquatic and terrestrial ecosystems until 1990 when he joined CH2M HILL. Dr. Ohlendorf’s experience there includes a wide variety of environmental projects, particularly focusing on ecological risk assessment and risk management, for which he provides firm-wide technical guidance.

Risk assessments have focused on a wide range of contaminants, ecological receptors, and ecosystems. He is a Certified Wildlife Biologist and serves as the Chair of The Wildlife Society’s Wildlife Toxicology Working Group. He has been recognized as a ‘‘Pioneer of

Selenium Research’’ for his extensive work related to selenium ecotoxicology.

Dr. Ohlendorf served on the Editorial Board of the journal Environmental Toxicology and Chemistry in 1987– 1989, and 2007–2010, and has authored more than 85 papers in the fields of ecotoxicology and vertebrate ecology (including 12 invited book chapters and 2 books edited/co-edited).

17. Rick Relyea, PhD, University of Pittsburgh, Pittsburgh, PA.

i. Expertise: Biology, ecology and ecotoxicology.


### 45562 Federal Register / Vol. 76, No. 146 / Friday, July 29, 2011 / Notices

ii. Education: B.S. in Environmental and Forest Biology (Wildlife Management) from State University of New York—Syracuse; M.S. in Wildlife Science (Wildlife Management) from Texas Tech University; PhD in Biology (Ecology, Evolution and Organismal Biology) from the University of Michigan.

iii. Professional Experience: Dr. Rick A. Relyea is a Professor of Biology at the University of Pittsburgh and Director of the Pymatuning Laboratory of Ecology. Dr. Relyea regularly teaches courses in ecology, evolution, and animal behavior at the undergraduate and graduate levels. For two decades, Dr. Relyea has conducted research on a wide range of topics including community ecology, evolution, disease ecology, and ecotoxicology. He has served on multiple scientific panels for the NSF

and has been an associate editor for the journals of the Ecological Society of

America. He has authored more than 80 scientific articles and book chapters, and has presented research seminars throughout the world. In 2005, he was named the ‘‘Chancellor’s Distinguished Researcher’’ at the University of Pittsburgh.

18. Lee Shugart, PhD, LR Shugart & Associates, Inc., Oak Ridge, TN.

i. Expertise: Biochemistry, environmental sciences, genetic ecotoxicology.

ii. Education: B.S. in Chemistry from East Tennessee State University; M.S. in Biochemistry and PhD in Microbiology from the University of Tennessee.

iii. Professional Experience: Dr. Lee Shugart is President of LR Shugart and Associates, Inc. His research interests are concerned with elucidating the

cellular mechanisms of environmental genotoxicants and the development of new methodologies for quantifying the interaction of genotoxicants with DNA and proteins. He has published over one hundred articles in the peer-reviewed, scientific literature on such topics as protein biosynthesis, mechanisms of enzyme action, and nucleic acid biochemistry, and has conducted

extensive research on the chemical modification of macromolecules by environmental contaminants in fish, rodents, and humans. He is considered an established authority on the use of the Biomarker Approach for evaluating

the effects of contaminants on the health of environmental species. He is the current and founding Editor-in-Chief of the international scientific journal Ecotoxicology, a past member of the

editorial board of Biomarkers and an

Associate Editor for the 2nd edition of

the Encyclopedia of Toxicology. He has

served as a Consultant to the Science Advisory Board of the EPA and as a Scientific Assistant to the Deputy Assistant to the Secretary of Defense for Nuclear and Chemical and Biological

Matters/Counter Proliferation. Dr. Shugart was a Line Officer in the U.S. Navy and served as a Communication Officer for the Chief of Naval Operation and as a Chief Engineer on a destroyer

stationed with the 6th fleet. He is a

veteran of the Korean Conflict.

19. Joseph P. Sullivan, PhD, Ardea Consulting, Woodland, CA.

i. Expertise: Pesticide ecotoxicology. ii. Education: B.A. in Biology from Ripon College; M.S. in Biology/Ecology from Utah State University; PhD in Wildlife Science from Virginia Polytechnic Institute & State University.

iii. Professional Experience: Dr. Joseph Sullivan is Principal Consultant/ Owner of Ardea Consulting. His work since graduate school has involved the evaluation of impacts of pesticides on terrestrial wildlife species. His graduate research investigated blood biomarkers indicative of reproductive impacts following exposure to organochlorine insecticides. Immediately following graduate school, he worked for 3 1 ⁄ 2 years as the avian toxicologist for a pesticide manufacturing company. Dr. Sullivan acted as Study Director conducting EPA guideline ecotoxicology tests according to Good Laboratory Practices. He also spent 3 years conducting field studies evaluating exposure to and impacts of pesticides to wildlife, primarily birds. This experience provided in-depth knowledge and understanding of the testing necessary for the registration of pesticides. In 1997, he established Ardea Consulting which he continues to operate in Woodland, CA, specializing in avian and wildlife biology/toxicology as well as ecological risk assessment. In 2009, Dr. Sullivan co-authored a chapter on impacts of environmental

contaminants on wildlife in the six volume compendium General and Applied Toxicology. In Pennsylvania, he served as President of the Pennsylvania Chapter of the Wildlife Society, member of the Pennsylvania Biodiversity Partnership, and Secretary of the Morrisville Environmental Advisory Council. He has served as Treasurer, Secretary and Vice Chair of the Wildlife Toxicology Working Group of The Wildlife Society. Now in California, Dr.

Sullivan serves on the Woodland Water Rate Advisory Committee.

20. Vasilis Vasiliou, Ph.D., University of Colorado Denver, Aurora, CO.

i. Expertise: Pharmacology & toxicology.

ii. Education: B.S. in Chemistry, Ph.D. in Biochemistry and postdoctoral training in Pharmacology from University of Ioannina, Greece; Postdoctoral training in Molecular Toxicology from the University of

Cincinnati.

iii. Professional Experience: Dr.

Vasilis Vasiliou is Professor of Molecular Toxicology at the Departments of Pharmaceutical Sciences and Ophthalmology at the University of

Colorado Denver. He is also Director of the Toxicology Graduate Program at the University of Colorado Denver since 2001, a program that has been ranked in the top 10 of the country. Dr. Vasiliou spent his one-year Sabbatical as a Guest Scientist at the National Eye Institute, National Institutes of Health (NIH 2005– 2006) in the laboratory of Molecular and Developmental Biology. Dr. Vasiliou’s major research interest has been the cellular responses to oxidative stress induced by physical agents ( e.g. . UV radiation), metabolism and toxicity of both endogenous and foreign chemicals. Dr. Vasiliou is a world expert in the Aldehyde Dehydrogenases (ALDH) and he maintains the official Web page for the ALDH superfamily. He is a Specialist Advisor for the Human Gene

Nomenclature Committee of the Human Genome Organization (HUGO). He is a member of ARVO (Cornea Specialty Section) and Society of Toxicology (Ocular Toxicology & Mechanisms Specialty Section). Dr Vasiliou’s research program has been funded since 1997, from NEI/NIH and NIAAA/NIH. He is the author of about 110 original scientific papers and review articles published in peer reviewed international journals as well as a number of book chapters and editorials. Dr. Vasiliou is the editor of the journal

Human Genomics and he is a member

of the Editorial Board of the Cutaneous and Ocular Toxicology, and The Ocular Surface.

List of Subjects

Environmental protection, Pesticides and pests.

Dated: July 21, 2011.

Frank Sanders,
Director, Office of Science Coordination and Policy.

[FR Doc. 2011–19174 Filed 7–28–11; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION**

**AGENCY**

**[FRL–9446–3]**

**Proposed Consent Decree, Clean Air**

**Act Citizen Suit**

**AGENCY :**  Environmental Protection Agency (EPA).